Does more intense palliative treatment improve overall survival in metastatic breast cancer patients?
- 1 February 1986
Abstract
A retrospective review of 483 women who had metastatic breast cancer and were treated between 1942 and 1975 was carried out to examine the effects of improving and aggressive palliative modalities on patient survival. There was a steady increase in the proportion of patients treated by chemotherapy and/or hormonal ablative therapy. Additive hormonal therapy, irradiation, and surgery for palliation decreased in frequency during the same period. Survival time from the first recurrence did not appear to increase in these patients over the period of this study. In spite of increasingly sophisticated palliative therapies, the survival time of patients with metastasis did not appear to be significantly prolonged.Keywords
This publication has 7 references indexed in Scilit:
- Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Comparison of consecutive series of patients in 1950s, 1960s, and 1970sCancer, 1985
- Survival of women with metastatic breast cancer at Yale from 1920 to 1980.Journal of Clinical Oncology, 1983
- Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breastCancer, 1980
- FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1980
- Combination chemotherapy for metastatic breast cancer.Comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomyCancer, 1978
- Response and survival in advanced breast cancer after two non-cross-resistant combinations.BMJ, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958